GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
ischaemic heart disease, heart failure or cerebrovascular disease
En fait, le rapport GSH/GS-SG dans les cellules est souvent utilis comme "indicateur" de l'tat oxydant et de la toxicit cellulaire de la cellule Sous la forme oxyde, deux glutathions sont runis par une liaison disulfure entre les deux cystines (GS-SG)
GLP-1 medications reproduce this at levels your body cant produce naturally, which is what makes them effective for weight loss
Additionally, its best to minimize products with artificial sweeteners, unnecessary fillers, and excessive additives, as these can compromise quality, digestibility, and overall health benefits